Genflow Biosciences (GENF.L) Stock Price
£1.93 1%
to add to portfolio
AI Score
-
Alternative
2 -
Fundamental
1 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Genflow Biosciences, AI stock picks, stock alerts and much more.
GENF.L AI Stock Analysis
AI stock analysis for GENF.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Genflow Biosciences (GENF.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Genflow Biosciences (GENF.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Genflow Biosciences (GENF.L), currently trading at £1.93, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About GENF.L
-
Genflow Biosciences plc operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing or halting the ageing process, and reducing the incidence of age-related diseases with increase in health span.
-
Symbol
GENF.L
-
Market
LSE
-
Industry
Biotechnology
-
Market Cap
6.6M
Similar Stocks
 |
Codexis 0I0X.L |
$3.98 3.5% |
3 |
 |
Oxford Nanopore Technologies plc ONT.L |
£129.3 0.5% |
4 |
 |
Sareum Holdings SAR.L |
£19.7 1% |
3 |
 |
Viridian Therapeutics 0K1R.L |
$17.56 0% |
5 |
 |
Avacta Group Plc AVCT.L |
£45.42 0.8% |
4 |
GENF.L Alternative Data
Web Traffic
Genflow Biosciences receives an estimated 4548 monthly visitors to genflowbio.com, which is up by 46.5% over the last month.
-
Web Traffic
4548
-
Change from Previous Month
46.5%
-
3 Month Change
60.1%
News Mentions
Genflow Biosciences was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Genflow Biosciences has 281 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.7% over the last month.
-
Twitter Followers
281
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
20.6%
Instagram Followers
Genflow Biosciences has 511 Instagram Followers on its main Instagram, down by -0.4% over the last month.
-
Instagram Followers
511
-
Daily Change
0.2%
-
1 Month Change
0.4%
-
3 Month Change
1%
Youtube Subscribers
Genflow Biosciences has 2 subscribers on its main Youtube channel.
-
Youtube Subscribers
2
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Genflow Biosciences has 7 employees.
-
LinkedIn Employees
7
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
40%
GENF.L Financials
GENF.L Key Metrics
-
Total Revenue
-£97K
-
Net Income
-£503.6K
-
Earnings per Share
-£0.0017
-
Free cash flow
-£404.6K
-
EBITDA
-£503.3K
-
EBITDA Ratio
5.18722
-
Total Assets
£1.1M
GENF.L 2-year Revenue & Income
GENF.L 2-year Free Cash Flow
GENF.L Technicals
GENF.L SMA
GENF.L RSI
FAQ
What's the current price of Genflow Biosciences (GENF.L) Stock?
The price of an Genflow Biosciences (GENF.L) share is £1.93.
What's the market cap of Genflow Biosciences?
The current market cap of Genflow Biosciences is 6.6M.
Should I buy or sell GENF.L?
Genflow Biosciences exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Genflow Biosciences a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Genflow Biosciences stock. There are several bearish signals and market challenges that could negatively impact Genflow Biosciences' future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Genflow Biosciences (GENF.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Genflow Biosciences stock right now, as the outlook appears bearish.
What are some stocks similar to Genflow Biosciences (GENF.L) that investors often compare it to?
Genflow Biosciences (GENF.L) is often compared to similar stocks such as Codexis, Oxford Nanopore Technologies plc, Sareum Holdings, Viridian Therapeutics and Avacta Group Plc.
What is the forecast for Genflow Biosciences' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Genflow Biosciences' stock price to be around £1.72 in 2026. Starting from the current price of £1.93, this represents a 10.7% change in price, indicating a bearish outlook for the stock.
How to buy Genflow Biosciences (GENF.L) Stock?
Genflow Biosciences stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Genflow Biosciences shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.